International Federation of Pharmaceutical Manufacturers & Associations
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents research-based pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Research-based pharmaceutical companies make a unique contribution to global health as innovators of life-saving and life-changing medicines and vaccines, which improved millions of lives around the world. Both IFPMA and its companies are involved in hundreds of partnerships, including the Access Accelerated initiative, a partnership of over 20 biopharmaceutical companies developing innovative and sustainable solutions to improve access to non-communicable disease (NCDs) treatment and care in low- and middle income countries. Access Accelerated also partners with the World Bank and the Union of International Cancer Control to help address the full spectrum of access barriers to NCD medicines. These partnerships involve the discovery of treatments that threaten health security or unduly put a burden on low-income countries, as well as support Universal Health Coverage (UHC) by expanding access to medicines and vaccines and strengthening health systems and in doing so, contribute to the Sustainable Development Goals (SDG 3 and SDG 17).
IFPMA hosts the Secretariat of the AMR Industry Alliance, a coalition of over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations that was formed to drive and measure industry progress to curb antimicrobial resistance. IFPMA also played a key role in establishing the AMR Action Fund, a ground-breaking initiative involving over 20 biopharmaceutical companies, that aims to bring 2-4 new antibiotics to patients by 2030.
Other initiatives supported by IFPMA include: The African Global Health Leaders Fellowship, the Africa Young Innovators for Health Award, and Fight the Fakes.
POSTED
09-13-22
R&D Based Biopharmaceutical Industry Statement in Support of the Seventh Global Fund Replenishment
POSTED
09-28-21
African Research Foundation Partners With International Pharmaceutical Industry to Strengthen Capacity for Health Innovation in Africa
POSTED
09-26-19
IFPMA Statement on UHC Political Declaration at UNGA74
IFPMA congratulates the United Nations General Assembly in holding the first-ever high-level meeting on Universal Health Coverage (UHC) and welcomes the adoption of the Political Declaration on UHC at its 74th session
IFPMA and its members welcome the declaration’s call to address healthca...
POSTED
09-12-19
New Report Provides a Policy Framework to Support Countries in Implementing an Effective Life-course Approach to Immunization
The report “Implementing a Life-Course Approach to Immunization” provides a policy framework for countries to implement effective policies in order to maximize individ...
POSTED
09-10-19
Industry and Stakeholders Reaffirm Their Commitment to Ensuring Ethics and Integrity Across Health Systems
IFPMA is proud to be a key partner of the Business Ethics for APEC SMEs initiative, the largest public-private partnership of its kind in the world with participation from more than 1,250 organizations across all 2...
POSTED
09-28-18
The R&D-based Biopharmaceutical Industry Welcomes the UN Declaration on NCDs and Calls for Innovative Financing Models and Multi-sectoral Collaboration
As an official UN interlocutor that shares knowledge and expertise to improve global health, IFPMA welcomes the strong re-affirmation of the commitment of governments to take steps to reduce premature mortality from chronic diseases by 2030 and strongly supports the declaration’s emphasis on orie...
POSTED
09-27-18
R&D-based Biopharmaceutical Industry Welcomes UN Declaration on TB
Yesterday, at the first-ever United Nations (UN) High-Level Meeting on Tuberculosis (TB), world health leaders agreed on a new, collaborative, focused, and forward-looking
POSTED
09-25-18
WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
WIPO and the research-based pharmaceutical industry today launched a new online tool designed to help procurement agencies better understand the global patent status of medicines.
The Patent Information Initiative for Medicines (Pat-INFORMED) is a unique resource where patent holders provi...
POSTED
05-24-18
International Alliance of Patients’ Organizations Joins Fight the Fakes as 36th Partner
Fight the Fakes is proud to announce that the International Alliance of Patients’ Organizations (IAPO) is joining as the campaign’s 36th partner. By signing up to jo...
POSTED
05-22-18
The Pharmaceutical Industry Advocates for Even Greater Collaboration as Critical to Future Global Health Progress
IFPMA launches today “50 Years of Global Health Progress”. The report traces global health progress over the past 50 years and the pioneering collaborative role the research-based biopharmaceutical industry has played not only to deliver pr...
